" /> Bevacizumab/Carboplatin/Gemcitabine Regimen - CISMeF





Preferred Label : Bevacizumab/Carboplatin/Gemcitabine Regimen;

NCIt synonyms : GC Plus Bev; Bevacizumab/Carboplatin/Gemcitabine; Gemcitabine/Carboplatin/Bevacizumab; Gemcitabine/Carboplatin/Bevacizumab Regimen; Avastin/Paraplatin/Gemzar; GC Bev;

NCIt related terms : Carboplatin and Gemcitabine (GCb) and Bevacizumab; Carboplatin and Gemcitabine (GCb) and Bevacizumab-maly; Carboplatin and Gemcitabine (GCb) and Bevacizumab-onbe; Carboplatin and Gemcitabine (GCb) and Bevacizumab-aybi; Carboplatin and Gemcitabine (GCb) and Bevacizumab-equi; Carboplatin and Gemcitabine (GCb) and Bevacizumab-awwb; Carboplatin and Gemcitabine (GCb) and Bevacizumab-bvzr; Carboplatin and Gemcitabine (GCb) and Bevacizumab-adcd;

NCIt definition : A regimen consisting of gemcitabine, carboplatin, and bevacizumab that may be used in the treatment of ovarian, fallopian tube, or primary peritoneal cancer.;

NCI Metathesaurus CUI : CL969482;

Codes from synonyms : 31967; 127202; 127424; 127646; 127498; 127350; 127572; 127276;

Details


You can consult :


Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.